Showing 1971-1980 of 2898 results for "".
- Introducing the Cutaneous Procedures Adverse Events Reporting (CAPER) Systemhttps://modernaesthetics.com/news/introducing-the-cutaneous-procedures-adverse-events-reporting-caper-system/2473065/The American Society for Dermatologic Surgery Association (ASDSA) and the Northwestern University Department of Dermatology are launching the Cutaneous Procedures Adverse Events Reporting (CAPER) system. This voluntary reporting system gathers patients’ adverse events (AEs) encoun
- It’s Settled: AbbVie and Evolus Come to Agreementhttps://modernaesthetics.com/news/its-settled-abbvie-and-evolus-come-to-agreement/2473064/AbbVie, Evolus, and Medytox have agreed to new settlement agreements to fully resolve all outstanding litigation, including the US International Trade Commission (ITC) case regarding the sale of Jeuveau®, between the companies. A California court case filed by Medytox against Evolus
- Industry Responds to COVID-19: Biopelle, Galderma US Aestheticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-biopelle-galderma-us-aesthetics/2473063/Biopelle One bright spot for many aesthetic practices during the COVID-19 pandemic has been persistent and perhaps increased demand for skincare. Biopelle has responded to support physicians who wish to dispense their products. “We offer a ski
- Evolus’ Jeuveau Can Stay on U.S. Market For Nowhttps://modernaesthetics.com/news/evolus-jeuveau-gets-stay-of-execution/2473061/Evolus Inc. can remain for sale in the U.S. temporarily while an appeals court re-considers an import ban won by AbbVie Inc.’s Allergan that was slated to go into effect on Feb. 16, 2021, according to
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- Soliton’s RAP Technology Cleared for Cellulitehttps://modernaesthetics.com/news/solitons-rap-technology-cleared-for-cellulite/2473057/The FDA has cleared Soliton Inc.’s Rapid Acoustic Pulse (RAP) technology for the short-term improvement in the appearance of cellulite. Harnessing the power of sound, the unique, rapid-pulsed technology safely and comfortably breaks apart the fibrous septa bands beneath the skin that cause
- FDA Greenlights Galderma's Restylane Defyne for Chin Augmentationhttps://modernaesthetics.com/news/fda-greenlights-galdermas-restylane-defyne-for-chin-augmentation/2473055/The U.S. Food and Drug Administration (FDA) has approved Restylane Defyne for the augmentation and correction of mild to moderate chin retrusion in adults over the age of 21. Restylane Defyne is a hyaluronic acid (HA) dermal filler that was first approved in 201
- Business News: Dominion Aesthetic Technologies Closes $23.7 Million Series B Financinghttps://modernaesthetics.com/news/business-news-dominion-aesthetic-technologies-closes-237-million-series-b-financing/2473052/Dominion Aesthetic Technologies, developers of EON, closed Series B financing, raising a total of $23.7 million. The series B funding will accelerate the manufacturing and commercialization of EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasi
- Pulse Biosciences Receives European Clearance for CellFX Systemhttps://modernaesthetics.com/news/pulse-biosciences-receives-european-clearance-for-cellfx-system/2473050/Pulse Biosciences, Inc. will proceed with its planned controlled launch of the CellFX System to medical practices within the European Union (EU), now that it has received CE mark for the system. The European clearance is for the treatment of general dermatologic conditions, includi
- Galderma Gives Back: New Face for Change Program Supports Dress for Success, Skin Cancer Foundationhttps://modernaesthetics.com/news/galderma-gives-back-new-face-for-change-program-supports-dress-for-success-skin-cancer-foundation/2473049/Galderma is launching Face for Change, a program in partnership with Dress for Success and The Skin Cancer Foundation that will allow Dysport users to give back with each treatment. Starting January 19, 2021 and ending February 28, 2021, Galderma will contribute $100